Browse medicines, page 27 of 34

Use listed on the medicine record

Discomfort associated with acute, painful musculoskeletal conditions

Use listed on the medicine record

Methohexital Sodium for Injection can be used in adults as follows: 1.For intravenous induction of anesthesia prior to the use of other general anesthetic agents. 2.For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; Methohexital Sodium for Injection may be given by infusion or intermittent injection.

Use listed on the medicine record

Absence (petit mal) seizures that are refractory to other drugs

Use listed on the medicine record

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

Use listed on the medicine record

Joint pain, muscle pain, and inflammation associated

Use listed on the medicine record

Metyrosine capsules are indicated in the treatment of patients with pheochromocytoma for: 1. Preoperative preparation of patients for surgery. 2. Management of patients when surgery is contraindicated. 3. Chronic treatment of patients with malignant pheochromocytoma. Metyrosine capsules are not recommended for the control of essential hypertension.

Use listed on the medicine record

Documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening

Use listed on the medicine record

Symptomatic orthostatic hypotension

Use listed on the medicine record

The treatment of adult patients

Use listed on the medicine record

GALAFOLD is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene ( GLA ) variant based on in vitro assay data [see Dosage and Administration (2.1) and Clinical Pharmacology (12.1) ] . This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate [see Clinical Studies (14) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Use listed on the medicine record

Fibromyalgia

Use listed on the medicine record

IMPAVIDO (miltefosine) capsules are indicated in adults and adolescents ≥12 years of age weighing ≥ 30 kg for the treatment of: Visceral leishmaniasis caused by Leishmania donovani [see Clinical Trials ( 14.1 )] . Cutaneous leishmaniasis caused by Leishmania braziliensis , Leishmania guyanensis , and Leishmania panamensis [see Clinical Trials ( 14.2 )] . Mucosal leishmaniasis caused by Leishmania braziliensis [see Clinical Trials ( 14.3 )] .

Use listed on the medicine record

MUTAMYCIN ® (Mitomycin) for Injection is not recommended as single-agent, primary therapy. It has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. Mitomycin is not recommended to replace appropriate surgery and/or radiotherapy.

Use listed on the medicine record

The nausea and vomiting associated with cancer chemotherapy

Use listed on the medicine record

Carefully consider the potential benefits and risks of nabumetone tablets and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Nabumetone tablets, USP are indicated: For relief of the signs and symptoms of rheumatoid arthritis. For relief of the signs and symptoms of osteoarthritis.

Use listed on the medicine record

Nafcillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. Culture and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug (see CLINICAL PHARMACOLOGY - Susceptibility Test Methods ). Nafcillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results. Nafcillin should not be used in infections caused by organisms susceptible to penicillin G.

Use listed on the medicine record

The emergency treatment of known or suspected overdose induced by natural or synthetic opioids

Use listed on the medicine record

First remove the protective cap, before first use, press several times until liquid squirts out, then insert the nozzle into the nostril, press firmly, pull the nozzle out of the nostril before releasing, then release, close the cap for protection.

Use listed on the medicine record

Depression

Use listed on the medicine record

The reversal of the effects of nondepolarizing neuromuscular blocking agents after surgery

Use listed on the medicine record

Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi [see Clinical Studies ( 14 )]

Use listed on the medicine record

Metastatic prostate cancer

Use listed on the medicine record

Mild-to-moderate coronavirus disease 2019

Use listed on the medicine record

Diarrhea caused by Giardia lamblia or Cryptosporidium parvum

Use listed on the medicine record

Active duodenal ulcer

Use listed on the medicine record

Adults and children 12 years of age and over: apply to affected area not more than 3 to 4 times daily. Children under 12 years of age: do not use, consult a doctor For easy application: partially peel back protective film and apply exposed patch to the site of pain. Carefully remove remaining film while pressing patch to skin for secure adhesion.

Use listed on the medicine record

Helps provide mimial protection agains sunburn. Higher SPF gives more sunburn protection. For skin that sunburns minimally.

Use listed on the medicine record

Acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate

Use listed on the medicine record

INDICATIONS & USAGE Oxaliplatin for injection USP, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: - adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. - treatment of advanced colorectal cancer. Oxaliplatin for injection USP is a platinum-based drug used in combination with infusional 5-fluorouracil/leucovorin, which is indicated for: - adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. - treatment of advanced colorectal cancer.

Use listed on the medicine record

USAGE After cleansing, hold the bottle 15-20 cm awayfrom your face, close your eyes, and gently mistevenly over the skin. Allow it to absorb naturallyor lightly pat for better penetration. Follow withyour regular skincare routine.

Use listed on the medicine record

Acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option

Use listed on the medicine record

for the temporary relief of: • bloating • water-weight gain • swelling • full feeling associated with the premenstrual and menstrual periods

Use listed on the medicine record

Moderate or severe hypercalcemia associated with malignancy, with or without bone metastases

Use listed on the medicine record

INDICATIONS & USAGE 1.1 Chronic Kidney Disease Stages 3 and 4 Paricalcitol Capsules are indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. Pediatric use information for patients 10 to 16 years of age is approved for AbbVie Inc.’s Zemplar (Paricalcitol) capsules. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Use listed on the medicine record

Intestinal amebiasis–acute and chronic

Use listed on the medicine record

The treatment of adults

Use listed on the medicine record

Recurrent herpes labialis

Use listed on the medicine record

Therapy Penicillin G Potassium for Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G.

Use listed on the medicine record

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Use listed on the medicine record

Parenteral Sedatives. Hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks. (See " Clinical Pharmacology " section.) Preanesthetics. Anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics.